Industry Presentations

Treatment Option for CML


  • NON

    A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy

    Speakers:Jorge Cortes, MD

    Duration: 60 minutes

    Presented on: November 4, 2020

    *This session is not eligible for AMA PRA Category 1 CreditsTM